Suzuki et al. reported that macrophage activation marker CD163 is found significantly higher in patients with active pulmonary TB than in control subjects, and its level is associated with mortality rate of pulmonary TB patients, indicating that CD163 may be a potential diagnosis and prognosis biomarker in pulmonary TB [10]. The gene discussed is CD163; the disease is pulmonary tuberculosis.